Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Double-Blind Method"" wg kryterium: Temat


Tytuł :
Blinding in Rehabilitation Research: Empirical Evidence on the Association Between Blinding and Treatment Effect Estimates.
Autorzy :
Armijo-Olivo S; From the University of Applied Sciences, Faculty of Business and Social Sciences, Osnabrück, Germany (SA-O); Faculty of Rehabilitation Medicine, Department of Physical Therapy, Rehabilitation Research Center, Edmonton, Alberta, Canada (SA-O, MD); Cochrane Rehabilitation, IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy (SA-O, CA); Scott Health Sciences Library, University of Alberta, Edmonton, Alberta, Canada (LD); IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy (CA); Department of Physical and Rehabilitation Medicine, Helsinki University Hospital, Helsinki, Finland (JA); University of Helsinki, Helsinki, Finland (JA); Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine and Centre for Rehabilitation Outcomes Research, Shirley Ryan AbilityLab, Chicago, Illinois (AWH); and Centre for Health and Social Economics, National Institute for Health and Welfare, Helsinki, Finland (AM).
Dennett L
Arienti C
Dahchi M
Arokoski J
Heinemann AW
Malmivaara A
Pokaż więcej
Źródło :
American journal of physical medicine & rehabilitation [Am J Phys Med Rehabil] 2020 Mar; Vol. 99 (3), pp. 198-209.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8803677 Publication Model: Print Cited Medium: Internet ISSN: 1537-7385 (Electronic) Linking ISSN: 08949115 NLM ISO Abbreviation: Am J Phys Med Rehabil Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Double-Blind Method*
Rehabilitation Research*
Research Design*
Outcome Assessment, Health Care/*statistics & numerical data
Humans
Czasopismo naukowe
Tytuł :
Fool's gold? Why blinded trials are not always best.
Autorzy :
Anand R; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Norrie J; Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
Bradley JM; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
McAuley DF; Wellcome-Wolfson Institute for Experimental Medicine, School of Medicine, Dentistry, and Biomedical Sciences, Queen's University Belfast, Belfast, UK.
Clarke M; Northern Ireland Clinical Trials Unit and Methodology Hub, Centre for Public Health, Queen's University Belfast, Belfast, UK.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2020 Jan 21; Vol. 368, pp. l6228. Date of Electronic Publication: 2020 Jan 21.
Typ publikacji :
Journal Article
Journal Info :
Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Clinical Trials as Topic*/organization & administration
Clinical Trials as Topic*/standards
Double-Blind Method*
Observer Variation*
Patient Safety*
Research Design/*standards
Data Accuracy ; Humans ; Outcome Assessment, Health Care/methods ; Outcome Assessment, Health Care/standards ; Randomized Controlled Trials as Topic/methods
Czasopismo naukowe
Tytuł :
Cariprazine for bipolar depression: What is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Autorzy :
Citrome L; New York Medical College, Valhalla, NY, USA.
Pokaż więcej
Źródło :
International journal of clinical practice [Int J Clin Pract] 2019 Oct; Vol. 73 (10), pp. e13397. Date of Electronic Publication: 2019 Aug 19.
Typ publikacji :
Journal Article; Systematic Review
Journal Info :
Publisher: Wiley Country of Publication: England NLM ID: 9712381 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-1241 (Electronic) Linking ISSN: 13685031 NLM ISO Abbreviation: Int. J. Clin. Pract. Subsets: MEDLINE
MeSH Terms :
Double-Blind Method*
Patient Selection*
Antipsychotic Agents/*therapeutic use
Bipolar Disorder/*drug therapy
Piperazines/*therapeutic use
Clinical Trials as Topic ; Humans ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Pharmacokinetics of maslinic and oleanolic acids from olive oil - Effects on endothelial function in healthy adults. A randomized, controlled, dose-response study.
Autorzy :
de la Torre R; Integrative Pharmacology and Systems Neuroscience Research Group, IMIM (Hospital del Mar Research Institute), Dr. Aiguader 88, 08003 Barcelona, Spain; UniversitatPompeuFabra (CEXS-UPF), Dr. Aiguader 88, 08003 Barcelona, Spain; CIBER de Fisiopatología Obesidad y Nutrición (CIBEROBN), Santiago de Compostela 15706, Spain. Electronic address: .
Carbó M; UniversitatPompeuFabra (CEXS-UPF), Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: .
Pujadas M; Integrative Pharmacology and Systems Neuroscience Research Group, IMIM (Hospital del Mar Research Institute), Dr. Aiguader 88, 08003 Barcelona, Spain; CIBER de Fisiopatología Obesidad y Nutrición (CIBEROBN), Santiago de Compostela 15706, Spain. Electronic address: .
Biel S; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental 'Alejandro Otero' (FIBAO), Granada, Spain. Electronic address: .
Mesa MD; Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology 'José Mataix', Biomedical Research Center, Health Science Technological Park, University of Granada, Avenida del Conocimiento s/n. 18100 Armilla, Granada, Spain; Instituto de Investigación Biosanitariaibs GRANADA, Complejo Hospitalario Universitario de Granada, Granada 18014, Spain. Electronic address: .
Covas MI; CIBER de Fisiopatología Obesidad y Nutrición (CIBEROBN), Santiago de Compostela 15706, Spain; NUPROAS (Nutritional Project Assessment), Handesbolag (NUPROAS HB), Nacka, Sweden.
Expósito M; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental 'Alejandro Otero' (FIBAO), Granada, Spain. Electronic address: .
Espejo JA; Instituto para la Calidad y Seguridad Alimentaria (ICSA), Granada, Spain.
Sanchez-Rodriguez E; Department of Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology 'José Mataix', Biomedical Research Center, Health Science Technological Park, University of Granada, Avenida del Conocimiento s/n. 18100 Armilla, Granada, Spain.
Díaz-Pellicer P; Integrative Pharmacology and Systems Neuroscience Research Group, IMIM (Hospital del Mar Research Institute), Dr. Aiguader 88, 08003 Barcelona, Spain.
Jimenez-Valladares F; Cooperativa San Francisco de Asís. Montefrío. Granada, Spain. Electronic address: .
Rosa C; Fundación Pública Andaluza para la Investigación Biosanitaria de Andalucía Oriental 'Alejandro Otero' (FIBAO), Granada, Spain. Electronic address: .
Pozo O; Integrative Pharmacology and Systems Neuroscience Research Group, IMIM (Hospital del Mar Research Institute), Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: .
Fitó M; CIBER de Fisiopatología Obesidad y Nutrición (CIBEROBN), Santiago de Compostela 15706, Spain; Cardiovascular Risk and Nutrition Research Group, IMIM (Hospital del Mar Research Institute), Dr. Aiguader 88, 08003 Barcelona, Spain. Electronic address: .
Pokaż więcej
Źródło :
Food chemistry [Food Chem] 2020 Aug 30; Vol. 322, pp. 126676. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: Elsevier Applied Science Publishers Country of Publication: England NLM ID: 7702639 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7072 (Electronic) Linking ISSN: 03088146 NLM ISO Abbreviation: Food Chem Subsets: MEDLINE
MeSH Terms :
Oleanolic Acid/*pharmacokinetics
Olive Oil/*metabolism
Triterpenes/*pharmacokinetics
Adult ; Blood Pressure ; Cross-Over Studies ; Double-Blind Method ; Endothelium/physiology ; Female ; Humans ; Male ; Middle Aged ; Oleanolic Acid/blood ; Oleanolic Acid/urine ; Olive Oil/chemistry ; Triterpenes/blood ; Triterpenes/urine ; Young Adult
Czasopismo naukowe
Tytuł :
Efficacy and adverse events of 4% articaine compared with 2% lidocaine on primary molar extraction: A randomised controlled trial.
Autorzy :
Massignan C; Department of Pediatric Dentistry, School of Dentistry, Federal University of Santa Catarina, Florianópolis, Brazil.
Silveira Santos P; Department of Pediatric Dentistry, School of Dentistry, Federal University of Santa Catarina, Florianópolis, Brazil.
Cardoso M; Department of Pediatric Dentistry, School of Dentistry, Federal University of Santa Catarina, Florianópolis, Brazil.
Bolan M; Department of Pediatric Dentistry, School of Dentistry, Federal University of Santa Catarina, Florianópolis, Brazil.
Pokaż więcej
Źródło :
Journal of oral rehabilitation [J Oral Rehabil] 2020 Aug; Vol. 47 (8), pp. 1031-1040. Date of Electronic Publication: 2020 May 25.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 0433604 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2842 (Electronic) Linking ISSN: 0305182X NLM ISO Abbreviation: J Oral Rehabil Subsets: Dentistry; MEDLINE
MeSH Terms :
Anesthesia, Dental*
Carticaine*
Anesthetics, Local ; Child ; Double-Blind Method ; Humans ; Lidocaine ; Molar
Czasopismo naukowe
Tytuł :
Effect of Diclofenac Potassium Premedication on Postendodontic Pain in Mandibular Molars with Symptomatic Irreversible Pulpitis: A Randomized Placebo-Controlled Double-Blind Trial.
Autorzy :
Al-Rawhani AH; Department of Endodontics, Faculty of Dentistry, Cairo University, Cairo, Egypt.
Gawdat SI; Department of Endodontics, Faculty of Dentistry, Cairo University, Cairo, Egypt.
Wanees Amin SA; Department of Endodontics, Faculty of Dentistry, Cairo University, Cairo, Egypt. Electronic address: .
Pokaż więcej
Źródło :
Journal of endodontics [J Endod] 2020 Aug; Vol. 46 (8), pp. 1023-1031. Date of Electronic Publication: 2020 May 26.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: Elsevier Country of Publication: United States NLM ID: 7511484 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3554 (Electronic) Linking ISSN: 00992399 NLM ISO Abbreviation: J Endod Subsets: Dentistry
MeSH Terms :
Pulpitis*
Diclofenac ; Double-Blind Method ; Humans ; Mandibular Nerve ; Molar ; Premedication ; Prospective Studies
Czasopismo naukowe
Tytuł :
Efficacy of quadruple treatment on different types of pre-operative anaemia: secondary analysis of a randomised controlled trial.
Autorzy :
Rössler J; Institute of Anesthesiology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Hegemann I; Department of Medical Oncology and Haematology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Schoenrath F; Department of Cardiothoracic and Vascular Surgery, German Heart Centre Berlin, German Centre for Cardiovascular Research, Berlin, Germany.
Seifert B; Department of Biostatistics, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland.
Kaserer A; Institute of Anesthesiology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Spahn GH; Institute of Anesthesiology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Falk V; Department of Cardiothoracic and Vascular Surgery, German Heart Centre Berlin, German Centre for Cardiovascular Research, Berlin, Germany.; Department of Cardiothoracic Surgery, Charité - Universitätsmedizin Berlin, Germany.; Department of Health Science and Technology, Swiss Federal Institute of Technology, Zürich, Switzerland.
Spahn DR; Institute of Anesthesiology, University of Zurich and University Hospital Zurich, Zurich, Switzerland.
Pokaż więcej
Źródło :
Anaesthesia [Anaesthesia] 2020 Aug; Vol. 75 (8), pp. 1039-1049. Date of Electronic Publication: 2020 Apr 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0370524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2044 (Electronic) Linking ISSN: 00032409 NLM ISO Abbreviation: Anaesthesia Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Anemia/*drug therapy
Preoperative Care/*methods
Administration, Intravenous ; Aged ; Aged, 80 and over ; Anemia, Iron-Deficiency/drug therapy ; Blood Transfusion/statistics & numerical data ; Cardiac Surgical Procedures/methods ; Double-Blind Method ; Drug Therapy, Combination ; Erythropoietin/administration & dosage ; Erythropoietin/therapeutic use ; Female ; Folic Acid/administration & dosage ; Folic Acid/therapeutic use ; Hematinics/administration & dosage ; Hematinics/therapeutic use ; Humans ; Iron/administration & dosage ; Iron/therapeutic use ; Male ; Middle Aged ; Postoperative Period ; Reticulocyte Count ; Vitamin B 12/administration & dosage ; Vitamin B 12/therapeutic use ; Vitamin B Complex/administration & dosage ; Vitamin B Complex/therapeutic use
Czasopismo naukowe
Tytuł :
A randomized double-blind clinical trial to evaluate the efficacy of chlorhexidine, antioxidant, and hyaluronic acid mouthwashes in the management of biofilm-induced gingivitis.
Autorzy :
Abdulkareem AA; College of Dentistry, University of Baghdad, Baghdad, Iraq.
Al Marah ZA; Faculty of Dentistry, Dijlah University College, Baghdad, Iraq.
Abdulbaqi HR; College of Dentistry, University of Baghdad, Baghdad, Iraq.
Alshaeli AJ; College of Dentistry, University of Baghdad, Baghdad, Iraq.
Milward MR; College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
Pokaż więcej
Źródło :
International journal of dental hygiene [Int J Dent Hyg] 2020 Aug; Vol. 18 (3), pp. 268-277. Date of Electronic Publication: 2020 Mar 20.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: Blackwell Pub Country of Publication: England NLM ID: 101168070 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1601-5037 (Electronic) Linking ISSN: 16015029 NLM ISO Abbreviation: Int J Dent Hyg Subsets: Dentistry; MEDLINE
MeSH Terms :
Anti-Infective Agents, Local*
Dental Plaque*
Gingivitis*
Antioxidants ; Biofilms ; Chlorhexidine ; Dental Plaque Index ; Double-Blind Method ; Humans ; Hyaluronic Acid ; Mouthwashes
Czasopismo naukowe
Tytuł :
Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03).
Autorzy :
Hamaguchi R; Department of Palliative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. .; Department of Stress Sciences and Psychosomatic Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan. .
Tsuchiya T; Department of Gastroenterological Surgery, Sendai City Medical Center, Sendai Open Hospital, Sendai, Miyagi, Japan.
Miyata G; Department of Gastroenterological Surgery, Iwate Prefectural Central Hospital, Morioka, Iwate, Japan.
Sato T; Department of Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan.
Takahashi K; Department of Colorectal Surgery, Tohoku Rosai Hospital, Sendai, Miyagi, Japan.
Miura K; Department of Surgery, Miyagi Cancer Center, Sendai, Miyagi, Japan.
Oshio H; Department of Surgery, Sendai Medical Center, Sendai, Miyagi, Japan.
Ohori H; Department of Clinical Oncology, Ishinomaki Red Cross Hospital, Ishinomaki, Miyagi, Japan.
Ariyoshi K; JORTC Data Center, Tokyo, Japan.
Oyamada S; JORTC Data Center, Tokyo, Japan.
Iwase S; Department of Palliative Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.; Department of Emergency & Palliative Medicine, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2020 Aug; Vol. 28 (8), pp. 3649-3657. Date of Electronic Publication: 2019 Dec 06.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
Journal Info :
Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Colorectal Neoplasms/*drug therapy
Cystine/*therapeutic use
Glutamates/*therapeutic use
Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Anorexia/chemically induced ; Anorexia/drug therapy ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Capecitabine/administration & dosage ; Capecitabine/adverse effects ; Chemotherapy, Adjuvant ; Colorectal Neoplasms/surgery ; Cystine/adverse effects ; Diarrhea/chemically induced ; Diarrhea/drug therapy ; Double-Blind Method ; Drug-Related Side Effects and Adverse Reactions/drug therapy ; Female ; Glutamates/adverse effects ; Hand-Foot Syndrome/drug therapy ; Hand-Foot Syndrome/etiology ; Humans ; Male ; Middle Aged ; Stomatitis/chemically induced ; Stomatitis/drug therapy
Czasopismo naukowe
Tytuł :
Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial.
Autorzy :
Burmester GR; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Free University and Humboldt University of Berlin, Berlin, Germany. Electronic address: .
Buttgereit F; Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Free University and Humboldt University of Berlin, Berlin, Germany.
Bernasconi C; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Álvaro-Gracia JM; Hospital General Universitario Gregorio Marañon, Universidad Complutense de Madrid, Spain.
Castro N; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Dougados M; Rheumatology Service, Université Paris-Descartes, Paris, France.
Gabay C; Department of Rheumatology, Hôpital Cochin, Geneva University Hospitals and Geneva School of Medicine, Geneva, Switzerland.
van Laar JM; University Medical Centre Utrecht, Utrecht, Netherlands.
Nebesky JM; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Pethoe-Schramm A; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Salvarani C; Department of Rheumatology and Clinical Immunology, Università di Modena e Reggio Emilia and Azienda unità sanitaria locale-IRCCS di Reggio Emilia, Reggio Emilia, Italy.
Donath MY; Department of Rheumatology, University Hospital Basel, Basel, Switzerland.
John MR; Pharmaceuticals Division, F Hoffmann-La Roche, Basel, Switzerland.
Pokaż więcej
Corporate Authors :
SEMIRA collaborators
Źródło :
Lancet (London, England) [Lancet] 2020 Jul 25; Vol. 396 (10246), pp. 267-276.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Elsevier Country of Publication: England NLM ID: 2985213R Publication Model: Print Cited Medium: Internet ISSN: 1474-547X (Electronic) Linking ISSN: 01406736 NLM ISO Abbreviation: Lancet Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Arthritis, Rheumatoid/*drug therapy
Glucocorticoids/*therapeutic use
Prednisone/*therapeutic use
Remission Induction/*methods
Administration, Intravenous ; Administration, Oral ; Adult ; Aged ; Antibodies, Monoclonal, Humanized/administration & dosage ; Antibodies, Monoclonal, Humanized/therapeutic use ; Arthritis, Rheumatoid/ethnology ; Double-Blind Method ; Drug Administration Schedule ; Drug Therapy, Combination ; Female ; France/epidemiology ; Germany/epidemiology ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Humans ; Injections, Subcutaneous ; Italy/epidemiology ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Russia/epidemiology ; Serbia/epidemiology ; Tunisia/epidemiology
Czasopismo naukowe
Tytuł :
Vitamin D Supplements for Prevention of Tuberculosis Infection and Disease.
Autorzy :
Ganmaa D; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Uyanga B; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Zhou X; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Gantsetseg G; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Delgerekh B; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Enkhmaa D; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Khulan D; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Ariunzaya S; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Sumiya E; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Bolortuya B; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Yanjmaa J; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Enkhtsetseg T; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Munkhzaya A; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Tunsag M; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Khudyakov P; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Seddon JA; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Marais BJ; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Batbayar O; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Erdenetuya G; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Amarsaikhan B; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Spiegelman D; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Tsolmon J; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Martineau AR; From the Harvard T.H. Chan School of Public Health (D.G., P.K., D.S.) and the Channing Division of Network Medicine, Brigham and Women's Hospital, Harvard Medical School (D.G.) - all in Boston; the Mongolian Health Initiative (D.G., B.U., G.G., D.E., D.K., S.A., E.S., B.B., J.Y., T.E., O.B.) and Global Laboratory (B.D., A.M.), Royal Plaza, Bayanzurkh District, the National Center for Communicable Diseases (M.T.), and the Mongolian National University of Medical Sciences (G.E., B.A., J.T.) - all in Ulaanbaatar, Mongolia; Yale School of Public Health, New Haven, CT (X.Z., D.S.); the Faculty of Medicine, Imperial College (J.A.S.), and the Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London (A.R.M.) - all in London; the Desmond Tutu Tuberculosis Centre, Department of Pediatrics and Child Health, Stellenbosch University, Cape Town, South Africa (J.A.S.); and the Faculty of Medicine and Health, University of Sydney, Sydney (B.J.M.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Jul 23; Vol. 383 (4), pp. 359-368.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info :
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N. Engl. J. Med. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Dietary Supplements*/adverse effects
Mycobacterium tuberculosis*/isolation & purification
Cholecalciferol/*therapeutic use
Latent Tuberculosis/*prevention & control
Vitamins/*therapeutic use
Child ; Cholecalciferol/adverse effects ; Double-Blind Method ; Female ; Follow-Up Studies ; Humans ; Incidence ; Latent Tuberculosis/epidemiology ; Male ; Respiratory Tract Infections/epidemiology ; Respiratory Tract Infections/prevention & control ; Treatment Failure ; Tuberculin Test ; Vitamin D/analogs & derivatives ; Vitamin D/blood ; Vitamins/adverse effects
Czasopismo naukowe
Tytuł :
Scent dog identification of samples from COVID-19 patients - a pilot study.
Autorzy :
Jendrny P; Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Hannover, Germany.
Schulz C; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
Twele F; Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Hannover, Germany.
Meller S; Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Hannover, Germany.
von Köckritz-Blickwede M; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.; Department of Physiological Chemistry, University of Veterinary Medicine Hannover, Hannover, Germany.
Osterhaus ADME; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
Ebbers J; Hörstel, Germany.
Pilchová V; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
Pink I; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Welte T; Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
Manns MP; Hannover Medical School, Hannover, Germany.
Fathi A; Department of Medicine, Division of Infectious Diseases, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.; Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; German Center for Infection Research, Hamburg-Lübeck, Borstel-Riems, Germany.
Ernst C; Central Institute of Medical Service, German Armed Forces, Koblenz, Germany.
Addo MM; Department of Medicine, Division of Infectious Diseases, University Medical-Center Hamburg-Eppendorf, Hamburg, Germany.; Department for Clinical Immunology of Infectious Diseases, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany.; German Center for Infection Research, Hamburg-Lübeck, Borstel-Riems, Germany.
Schalke E; Bundeswehr School of Dog handling, German Armed Forces, Ulmen, Germany.
Volk HA; Department of Small Animal Medicine and Surgery, University of Veterinary Medicine Hannover, Hannover, Germany. .
Pokaż więcej
Źródło :
BMC infectious diseases [BMC Infect Dis] 2020 Jul 23; Vol. 20 (1), pp. 536. Date of Electronic Publication: 2020 Jul 23.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect. Dis. Subsets: MEDLINE
MeSH Terms :
Betacoronavirus/*isolation & purification
Coronavirus Infections/*diagnosis
Coronavirus Infections/*virology
Mass Screening/*methods
Odorants/*analysis
Pneumonia, Viral/*diagnosis
Pneumonia, Viral/*virology
Animals ; Bronchi/chemistry ; Bronchi/virology ; Case-Control Studies ; Dogs ; Double-Blind Method ; Humans ; Pandemics/prevention & control ; Pilot Projects ; Saliva/chemistry ; Saliva/virology ; Sensitivity and Specificity
SCR Disease Name :
COVID-19
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Czasopismo naukowe
Tytuł :
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts.
Autorzy :
Ikematsu H; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Hayden FG; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Kawaguchi K; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Kinoshita M; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
de Jong MD; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Lee N; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Takashima S; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Noshi T; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Tsuchiya K; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Uehara T; From Ricerca Clinica, Fukuoka (H.I.), and Shionogi, Osaka (K.K., M.K., S.T., T.N., K.T., T.U.) - both in Japan; the Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia School of Medicine, Charlottesville (F.G.H.); the Department of Medical Microbiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam (M.D.J.); and the Division of Infectious Diseases, Department of Medicine, University of Alberta, Edmonton, Canada (N.L.).
Pokaż więcej
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Jul 23; Vol. 383 (4), pp. 309-320. Date of Electronic Publication: 2020 Jul 08.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N. Engl. J. Med. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Influenza A virus*/genetics
Influenza A virus*/isolation & purification
Antiviral Agents/*therapeutic use
Disease Transmission, Infectious/*prevention & control
Influenza, Human/*prevention & control
Oxazines/*therapeutic use
Pyridines/*therapeutic use
Thiepins/*therapeutic use
Triazines/*therapeutic use
Administration, Oral ; Adolescent ; Adult ; Aged ; Antiviral Agents/administration & dosage ; Antiviral Agents/adverse effects ; Child ; Child, Preschool ; Double-Blind Method ; Endonucleases/antagonists & inhibitors ; Family ; Female ; Humans ; Influenza, Human/transmission ; Influenza, Human/virology ; Intention to Treat Analysis ; Male ; Middle Aged ; Oxazines/administration & dosage ; Oxazines/adverse effects ; Pyridines/administration & dosage ; Pyridines/adverse effects ; Reverse Transcriptase Polymerase Chain Reaction ; Thiepins/administration & dosage ; Thiepins/adverse effects ; Triazines/administration & dosage ; Triazines/adverse effects
Czasopismo naukowe
Tytuł :
Effect of Levothyroxine on Left Ventricular Ejection Fraction in Patients With Subclinical Hypothyroidism and Acute Myocardial Infarction: A Randomized Clinical Trial.
Autorzy :
Jabbar A; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.; Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Ingoe L; Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.; Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom.
Junejo S; Department of Endocrinology and Cardiology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom.
Carey P; Department of Endocrinology and Cardiology, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, United Kingdom.
Addison C; Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom.
Thomas H; Department of Cardiology, Northumbria Healthcare NHS Foundation Trust, Cramlington, United Kingdom.
Parikh JD; Newcastle Magnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Austin D; Department of Cardiology, South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom.
Hollingsworth KG; Newcastle Magnetic Resonance Centre, Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
Stocken DD; Leeds Institute of Clinical Trials Research, University of Leeds, United Kingdom.
Pearce SHS; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.; Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Greenwood JP; Leeds University and Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
Zaman A; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.; Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.
Razvi S; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.; Department of Endocrinology, Gateshead Health NHS Foundation Trust, Gateshead, United Kingdom.
Pokaż więcej
Źródło :
JAMA [JAMA] 2020 Jul 21; Vol. 324 (3), pp. 249-258.
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Hypothyroidism/*complications
Non-ST Elevated Myocardial Infarction/*complications
ST Elevation Myocardial Infarction/*complications
Stroke Volume/*drug effects
Thyroxine/*pharmacology
Ventricular Function, Left/*drug effects
Depression ; Double-Blind Method ; Female ; Health Status ; Humans ; Hypothyroidism/blood ; Hypothyroidism/drug therapy ; Hypothyroidism/physiopathology ; Male ; Middle Aged ; Non-ST Elevated Myocardial Infarction/pathology ; Non-ST Elevated Myocardial Infarction/physiopathology ; Patient Reported Outcome Measures ; Quality of Life ; ST Elevation Myocardial Infarction/pathology ; ST Elevation Myocardial Infarction/physiopathology ; Sample Size ; Thyrotropin/blood ; Thyroxine/adverse effects ; Time Factors ; United Kingdom
Czasopismo naukowe
Tytuł :
Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice.
Autorzy :
Kaptchuk TJ; Beth Israel Hospital/Harvard Medical School, Boston, MA 02139, USA.; Contributed equally.
Hemond CC; University of Massachusetts Medical School, Worcester, MA 01655, USA.; Contributed equally.
Miller FG; Weill Cornell Medicine, New York, NY 10065, USA.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2020 Jul 20; Vol. 370, pp. m1668. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article; Review
Journal Info :
Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Chronic Pain/*drug therapy
Physician-Patient Relations/*ethics
Placebos/*adverse effects
Practice Patterns, Physicians'/*ethics
Bayes Theorem ; Chronic Pain/psychology ; Deception ; Double-Blind Method ; Ethics, Medical ; Humans ; Placebo Effect ; Placebos/administration & dosage ; Practice Patterns, Physicians'/statistics & numerical data
Czasopismo naukowe
Tytuł :
Efficacy and safety of epidural steroid injection following discectomy for patients with lumbar disc herniation: A protocol.
Autorzy :
Cai J; Department of Orthopedics II, The No.2 People's Hospital of Yibin, Sichuan Province, China.
Jiang W
Qiu B
Song Y
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Jul 17; Vol. 99 (29), pp. e21220.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Diskectomy*
Lumbar Vertebrae*
Glucocorticoids/*therapeutic use
Intervertebral Disc Displacement/*surgery
Analgesia, Patient-Controlled ; Double-Blind Method ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Humans ; Injections, Epidural ; Pain Measurement ; Pain, Postoperative ; Postoperative Period ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia: A 16-week, multicenter, randomized, double-blind, sham device-controlled trial.
Autorzy :
Yoon JS; aDepartment of Plastic and Reconstructive Surgery, DongGuk University Ilsan Medical Center, Goyang, South Korea bDepartment of Plastic and Reconstructive Surgery, Hanyang University Medical Center, Hanyang University College of Medicine, Seoul cDepartment of Plastic and Reconstructive Surgery, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
Ku WY
Lee JH
Ahn HC
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 Jul 17; Vol. 99 (29), pp. e21181.
Typ publikacji :
Journal Article; Randomized Controlled Trial
Journal Info :
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Alopecia/*urine
Head Protective Devices/*standards
Low-Level Light Therapy/*standards
Adult ; Aged ; Alopecia/physiopathology ; Double-Blind Method ; Equipment Design/methods ; Female ; Head Protective Devices/statistics & numerical data ; Humans ; Low-Level Light Therapy/methods ; Low-Level Light Therapy/statistics & numerical data ; Male ; Middle Aged ; Placebos/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Trial of Roflumilast Cream for Chronic Plaque Psoriasis.
Autorzy :
Lebwohl MG; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Papp KA; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Stein Gold L; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Gooderham MJ; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Kircik LH; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Draelos ZD; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Kempers SE; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Zirwas M; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Smith K; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Osborne DW; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Trotman ML; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Navale L; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Merritt C; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Berk DR; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Welgus H; From the Icahn School of Medicine at Mount Sinai, New York (M.G.L., L.H.K.); Probity Medical Research and K. Papp Clinical Research, Waterloo (K.A.P.), and the SkiN Centre for Dermatology, Probity Medical Research and Queen's University, Peterborough (M.J.G.) - both in Ontario, Canada; Henry Ford Medical Center, Detroit (L.S.G.); Indiana Medical Center, Indianapolis (L.H.K.); Physicians Skin Care and DermResearch, Louisville, KY (L.H.K.); Dermatology Consulting Services, High Point, NC (Z.D.D.); Minnesota Clinical Study Center, Fridley (S.E.K.); Dermatologists of the Central States, Probity Medical Research, and Ohio University, Bexley (M.Z.); and Arcutis Biotherapeutics, Westlake Village (K.S., D.W.O., L.N., C.M., D.R.B., H.W.), and ML Trotman Consulting, Newbury Park (M.-L.T.) - both in California.
Pokaż więcej
Corporate Authors :
ARQ-151 201 Study Investigators
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Jul 16; Vol. 383 (3), pp. 229-239.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N. Engl. J. Med. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Aminopyridines/*administration & dosage
Benzamides/*administration & dosage
Phosphodiesterase 4 Inhibitors/*administration & dosage
Psoriasis/*drug therapy
Skin Cream/*administration & dosage
Administration, Topical ; Adult ; Aminopyridines/adverse effects ; Benzamides/adverse effects ; Cyclopropanes/administration & dosage ; Cyclopropanes/adverse effects ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Least-Squares Analysis ; Male ; Middle Aged ; Phosphodiesterase 4 Inhibitors/adverse effects ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA.
Autorzy :
Johnston SC; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Amarenco P; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Denison H; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Evans SR; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Himmelmann A; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
James S; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Knutsson M; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Ladenvall P; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Molina CA; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Wang Y; From the Dean's Office, Dell Medical School, University of Texas at Austin, Austin (S.C.J.); the Department of Neurology and Stroke Center, Bichat-Claude Bernard Hospital, University of Paris, Paris (P.A.); Biopharmaceuticals Research and Development, AstraZeneca, Gothenburg (H.D., A.H., M.K., P.L.), and the Department of Medical Sciences, Uppsala University, Uppsala (S.J.) - both in Sweden; the Biostatistics Center, George Washington University, Washington, DC (S.R.E.); the Stroke Unit, Vall d'Hebron Hospital, Barcelona (C.A.M.); and the Department of Neurology, Tiantan Hospital, Capital Medical University, Beijing (Y.W.).
Pokaż więcej
Corporate Authors :
THALES Investigators
Źródło :
The New England journal of medicine [N Engl J Med] 2020 Jul 16; Vol. 383 (3), pp. 207-217.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info :
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N. Engl. J. Med. Subsets: Core Clinical (AIM); MEDLINE
MeSH Terms :
Aspirin/*therapeutic use
Ischemic Attack, Transient/*drug therapy
Platelet Aggregation Inhibitors/*therapeutic use
Stroke/*drug therapy
Ticagrelor/*therapeutic use
Aged ; Aged, 80 and over ; Aspirin/adverse effects ; Disability Evaluation ; Double-Blind Method ; Drug Therapy, Combination ; Female ; Hemorrhage/chemically induced ; Humans ; Ischemic Attack, Transient/complications ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/therapeutic use ; Secondary Prevention ; Stroke/complications ; Stroke/mortality ; Stroke/prevention & control ; Ticagrelor/adverse effects
Czasopismo naukowe
Tytuł :
Test and treat COVID 65 plus - Hydroxychloroquine versus placebo in early ambulatory diagnosis and treatment of older patients with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Autorzy :
Göpel S; Department of Internal Medicine 1, University Hospital Tübingen, Tübingen, Germany. .
Bethge W; Department Internal Medicine 2, University Hospital Tübingen, Tübingen, Germany.
Martus P; Institute for Clinical Epidemiology and Applied Biostatistics, University of Tübingen, Tübingen, Germany.
Kreth F; Department of Internal Medicine 1, University Hospital Tübingen, Tübingen, Germany.
Iftner T; Department of Virology, University Hospital Tübingen, Tübingen, Germany.
Joos S; Department of General Medicine, University Hospital Tübingen, Tübingen, Germany.
Döbele S; Department of Internal Medicine 1, University Hospital Tübingen, Tübingen, Germany.
Mordmüller B; Institute for Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Kremsner P; Institute for Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Ettrich T; Medical Clinic 1, University Hospital Ulm, Ulm, Germany.
Seufferlein T; Medical Clinic 1, University Hospital Ulm, Ulm, Germany.
Bitzer M; Department of Internal Medicine 1, University Hospital Tübingen, Tübingen, Germany.
Malek N; Department of Internal Medicine 1, University Hospital Tübingen, Tübingen, Germany.
Pokaż więcej
Źródło :
Trials [Trials] 2020 Jul 10; Vol. 21 (1), pp. 635. Date of Electronic Publication: 2020 Jul 10.
Typ publikacji :
Clinical Trial Protocol; Letter
Journal Info :
Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
MeSH Terms :
Ambulatory Care*
Clinical Laboratory Techniques*
Antiviral Agents/*administration & dosage
Betacoronavirus/*drug effects
Coronavirus Infections/*drug therapy
Hydroxychloroquine/*administration & dosage
Pneumonia, Viral/*drug therapy
Age Factors ; Aged ; Aging ; Antiviral Agents/adverse effects ; Betacoronavirus/pathogenicity ; Cause of Death ; Coronavirus Infections/diagnosis ; Coronavirus Infections/mortality ; Coronavirus Infections/virology ; Double-Blind Method ; Drug Administration Schedule ; Female ; Germany ; Hospitalization ; Host-Pathogen Interactions ; Humans ; Hydroxychloroquine/adverse effects ; Male ; Multicenter Studies as Topic ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/mortality ; Pneumonia, Viral/virology ; Predictive Value of Tests ; Randomized Controlled Trials as Topic ; Risk Factors ; Time Factors ; Treatment Outcome
SCR Disease Name :
COVID-19
SCR Protocol :
COVID-19 diagnostic testing; COVID-19 drug treatment
SCR Organism :
severe acute respiratory syndrome coronavirus 2
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies